Pear Therapeutics, Inc.

Thimble Point Acquisition Corp (Nasdaq: THMA), a healthcare-focused blank check company that completed its initial public offering in early 2021, filed a Form 10-Q with the Securities and Exchange Commission on May 24, 2021, documenting its operations during the pre-combination period. Sponsored by Thimble Point LLC, the vehicle targeted opportunities in the digital health and therapeutics sector. THMA subsequently announced and completed a business combination with Pear Therapeutics, a prescription digital therapeutics developer whose software-based treatments addressed conditions including substance use disorder and insomnia, bringing the company to public markets. For full filing history, sponsor data, and deal analytics on THMA and the broader SPAC universe, sign up for complete access at SpacDesk.